- Type / Class
- Equity / Common Stock
- Shares outstanding
- 18,303,310
- Total 13F shares
- 48,587,379
- Share change
- -1,907,768
- Total reported value
- $187,047,220
- Put/Call ratio
- 140%
- Price per share
- $3.85
- Number of holders
- 118
- Value change
- -$5,223,928
- Number of buys
- 60
- Number of sells
- 60
Quarterly Holders Quick Answers
What is CUSIP 690145107?
CUSIP 690145107 identifies OM - Outset Medical Inc - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 690145107:
Top shareholders of OM - Outset Medical Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
38%
|
6,947,871
|
$15,424,274 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
28%
|
5,112,408
|
$11,349,545 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
22%
|
4,011,876
|
$8,906,365 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
18%
|
3,266,257
|
$7,251,091 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
17%
|
3,114,700
|
$6,914,634 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
16%
|
2,893,220
|
$6,422,948 | — | 31 Mar 2024 | |
| BRAIDWELL LP |
13F
|
Company |
13%
|
2,400,427
|
$5,328,948 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
9.2%
|
1,685,410
|
$3,741,610 | — | 31 Mar 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
8.8%
|
1,604,261
|
$3,561,460 | — | 31 Mar 2024 | |
| Mubadala Investment Co PJSC |
13F
|
Company |
7.9%
|
1,440,601
|
$3,198,134 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
6.7%
|
1,223,487
|
$2,716,141 | — | 31 Mar 2024 | |
| PFM Health Sciences, LP |
13F
|
Company |
6.4%
|
1,168,035
|
$2,593,038 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
6%
|
1,102,235
|
$2,447,246 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
5.5%
|
1,009,474
|
$2,241,032 | — | 31 Mar 2024 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
5.5%
|
1,000,000
|
$2,220,000 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
5.2%
|
944,845
|
$2,097,556 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
4.3%
|
779,242
|
$1,728,000 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
4.2%
|
771,531
|
$1,712,796 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
3.8%
|
704,196
|
$1,563,315 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
3.3%
|
607,890
|
$1,349,516 | — | 31 Mar 2024 | |
| Bellevue Group AG |
13F
|
Company |
3.1%
|
572,359
|
$1,270,637 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
3%
|
540,571
|
$1,200,000 | — | 31 Mar 2024 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
2.9%
|
523,860
|
$1,162,000 | — | 31 Mar 2024 | |
| Steven S. Williamson |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
320,347
|
$1,143,639 | — | 15 Feb 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
2.6%
|
476,800
|
$1,058,496 | — | 31 Mar 2024 | |
| NORGES BANK |
13F
|
Company |
2.5%
|
461,400
|
$1,024,308 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.5%
|
452,388
|
$1,004,000 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
2.3%
|
420,205
|
$932,855 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
2.2%
|
403,657
|
$896,119 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
2.2%
|
398,006
|
$883,573 | — | 31 Mar 2024 | |
| Jean-Olivier Racine |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
265,325
|
$867,613 | — | 10 May 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.9%
|
345,343
|
$766,661 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.8%
|
326,152
|
$724,058 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.5%
|
281,983
|
$626,002 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.2%
|
225,845
|
$501,375 | — | 31 Mar 2024 | |
| Susquehanna Portfolio Strategies, LLC |
13F
|
Company |
1.2%
|
211,119
|
$468,684 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.1%
|
203,916
|
$452,694 | — | 31 Mar 2024 | |
| Martin Vazquez |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
146,619
mixed-class rows
|
$442,350 | — | 01 Mar 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
191,171
|
$424,400 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1%
|
185,237
|
$411,226 | — | 31 Mar 2024 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.12%
|
21,296
|
$399,087 | — | 31 Mar 2024 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.96%
|
176,161
|
$391,077 | — | 31 Mar 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.9%
|
165,597
|
$367,625 | — | 31 Mar 2024 | |
| PDT Partners, LLC |
13F
|
Company |
0.87%
|
158,377
|
$351,597 | — | 31 Mar 2024 | |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM |
13F
|
Company |
0.1%
|
18,842
|
$346,693 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.85%
|
155,285
|
$344,732 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.76%
|
139,669
|
$310,065 | — | 31 Mar 2024 | |
| James F. Hinrichs. |
3/4/5
|
Director |
—
class O/S missing
|
80,349
|
$283,632 | — | 29 May 2024 | |
| Stacey L. Porter |
3/4/5
|
Chief People Officer |
—
class O/S missing
|
61,448
|
$263,612 | — | 12 Jan 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.61%
|
111,111
|
$246,666 | — | 31 Mar 2024 |
Institutional Holders of Outset Medical Inc - Common Stock (OM) as of Q2 2024
As of 30 Jun 2024,
Outset Medical Inc - Common Stock (OM) was held by
118 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,587,379 shares.
The largest 10 holders included
FMR LLC, AMERIPRISE FINANCIAL INC, MORGAN STANLEY, JPMORGAN CHASE & CO, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, Assenagon Asset Management S.A., GMT CAPITAL CORP, and Mubadala Investment Co PJSC.
This page lists
119
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
109
Q2 2024 holders
118
Holder diff
9
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.